Lista de obras - Catherine Orrell - Dominio Público Uruguay

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

artículo científico publicado en 2023

Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate

artículo científico publicado en 2001

Adherence is not a barrier to successful antiretroviral therapy in South Africa

article

Adherence to HIV Antiretroviral Therapy in Resource-limited Settings

article

Antiretroviral adherence in a resource-poor setting

artículo científico publicado en 2005

Antiretroviral therapy adherence support: recommendations and future directions

artículo científico

CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study

artículo científico publicado en 2016

Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa

artículo científico publicado en 2011

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

artículo científico publicado en 2009

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans

article

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

artículo científico publicado en 2005

Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation

article

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

artículo científico publicado en 2005

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa

artículo científico publicado en 2011

Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?

artículo científico publicado en 2011

Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa

artículo científico publicado en 2011

Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy

artículo científico publicado en 2016

Efficacy and safety of lersivirine versus etravirine for the treatment of HIV-1 infection in patients with prior non-nucleoside reverse transcriptase inhibitor (NNRTI) use and evidence of NNRTI resistance: a randomized phase 2B trial

artículo científico publicado en 2014

Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings

artículo científico publicado en 2006

Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages

scholarly article by Stephen Lawn et al published January 2009 in AIDS

Healthcare utilization of patients accessing an African national treatment program

artículo científico publicado en 2007

Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppression

artículo científico publicado en 2013

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

artículo científico publicado en 2004

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa

artículo científico publicado en 2010

Limited use for dual treatment with boosted protease inhibitors plus lamivudine in first-line antiretroviral therapy

artículo científico publicado en 2015

Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa

artículo científico publicado en 2010

Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment

artículo científico publicado en 2008

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial

artículo científico publicado en 2013

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy

artículo científico publicado en 2011

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality

artículo científico publicado en 2009

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

artículo científico publicado en 2013

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

artículo científico publicado en 2010

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.

artículo científico publicado en 2011

Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection

artículo científico publicado en 2017

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers

artículo científico publicado en 2008

Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets

artículo científico publicado en 2011

Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania

artículo científico publicado en 2017

Psychotropic prescribing in HIV

article

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared

artículo científico publicado en 2008

Rates of switching antiretroviral drugs in a primary care service in South Africa before and after introduction of tenofovir

artículo científico publicado en 2013

Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy

artículo científico publicado en 2013

Simplifying HIV cohort monitoring--pharmacy stock records minimize resources necessary to determine retention in care

artículo científico publicado en 2013

Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020

scientific article published on 10 December 2020

Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting

artículo científico publicado en 2011

Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

artículo científico publicado en 2013

Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa

artículo científico publicado en 2011

Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors

artículo científico publicado en 2010

Twenty-four-month outcomes from a cluster-randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs

artículo científico publicado en 2020

Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa

artículo científico publicado en 2012

Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy

artículo científico publicado en 2011

Lista de obras de Catherine Orrell

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate

Adherence is not a barrier to successful antiretroviral therapy in South Africa

Adherence to HIV Antiretroviral Therapy in Resource-limited Settings

Antiretroviral adherence in a resource-poor setting

Antiretroviral therapy adherence support: recommendations and future directions

CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study

Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa

Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?

Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa

Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy

Efficacy and safety of lersivirine versus etravirine for the treatment of HIV-1 infection in patients with prior non-nucleoside reverse transcriptase inhibitor (NNRTI) use and evidence of NNRTI resistance: a randomized phase 2B trial

Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings

Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages

Healthcare utilization of patients accessing an African national treatment program

Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppression

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa

Limited use for dual treatment with boosted protease inhibitors plus lamivudine in first-line antiretroviral therapy

Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa

Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.

Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers

Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets

Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania

Psychotropic prescribing in HIV

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared

Rates of switching antiretroviral drugs in a primary care service in South Africa before and after introduction of tenofovir

Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy

Simplifying HIV cohort monitoring--pharmacy stock records minimize resources necessary to determine retention in care

Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020

Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting

Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa

Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors

Twenty-four-month outcomes from a cluster-randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs

Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa

Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy